FDA provides guidance on device modifications
This article was originally published in Clinica
The FDA has released a revised version of its controversial guidance document on when to submit a 510(k) for a change to an existing device. Gone is the "matrix model" of the original (April 1994) draft. "The matrix appeared to confuse many more people than it helped," the FDA admits.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.